The genetic defect-adenosine deaminase (ADA) deficiency may be cured permanently by
A. Periodic infusion of genetically engineered lymphocytes having functional ADA CDNA
B. Enzyme replacement therapy
C. Administering adenosine deaminase activators
D. Introducing bone marrow cells producing ADA into cells at early embryonic stages
